Outcome measures in coeliac disease trials: the Tampere recommendations. 2018

Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

A gluten-free diet is the only treatment option of coeliac disease, but recently an increasing number of trials have begun to explore alternative treatment strategies. We aimed to review the literature on coeliac disease therapeutic trials and issue recommendations for outcome measures. Based on a literature review of 10 062 references, we (17 researchers and 2 patient representatives from 10 countries) reviewed the use and suitability of both clinical and non-clinical outcome measures. We then made expert-based recommendations for use of these outcomes in coeliac disease trials and identified areas where research is needed. We comment on the use of histology, serology, clinical outcome assessment (including patient-reported outcomes), quality of life and immunological tools including gluten immunogenic peptides for trials in coeliac disease. Careful evaluation and reporting of outcome measures will increase transparency and comparability of coeliac disease therapeutic trials, and will benefit patients, healthcare and the pharmaceutical industry.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D002446 Celiac Disease A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION. Gluten Enteropathy,Sprue, Celiac,Sprue, Nontropical,Celiac Sprue,Gluten-Sensitive Enteropathy,Sprue,Disease, Celiac,Enteropathies, Gluten,Enteropathies, Gluten-Sensitive,Enteropathy, Gluten,Enteropathy, Gluten-Sensitive,Gluten Enteropathies,Gluten Sensitive Enteropathy,Gluten-Sensitive Enteropathies,Nontropical Sprue
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017063 Outcome Assessment, Health Care Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). Assessment, Outcome,Outcome Assessment,Outcome Assessment (Health Care),Outcomes Research,Assessment, Outcomes,Outcome Measures,Outcome Studies,Outcomes Assessment,Assessment, Outcome (Health Care),Assessments, Outcome,Assessments, Outcome (Health Care),Assessments, Outcomes,Measure, Outcome,Measures, Outcome,Outcome Assessments,Outcome Assessments (Health Care),Outcome Measure,Outcome Study,Outcomes Assessments,Research, Outcomes,Studies, Outcome,Study, Outcome
D057240 Patient Preference Individual's expression of desirability or value of one course of action, outcome, or selection in contrast to others. Patient Preferences,Preference, Patient,Preferences, Patient

Related Publications

Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
October 1990, Acta paediatrica Scandinavica,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
August 2017, The Clinical journal of pain,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
January 2018, Gut,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
January 2005, Pain,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
January 2017, Handbook of clinical neurology,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
December 2006, Pain,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
January 2016, Drug and alcohol dependence,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
May 2022, Translational neurodegeneration,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
August 2016, Alimentary pharmacology & therapeutics,
Jonas F Ludvigsson, and Carolina Ciacci, and Peter Hr Green, and Katri Kaukinen, and Ilma R Korponay-Szabo, and Kalle Kurppa, and Joseph A Murray, and Knut Erik Aslaksen Lundin, and Markku J Maki, and Alina Popp, and Norelle R Reilly, and Alfonso Rodriguez-Herrera, and David S Sanders, and Detlef Schuppan, and Sarah Sleet, and Juha Taavela, and Kristin Voorhees, and Marjorie M Walker, and Daniel A Leffler
May 2022, Translational neurodegeneration,
Copied contents to your clipboard!